REVLIMID Adverse Event: Vaginal haemorrhage
REVLIMID Adverse Event: Vaginal haemorrhage is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: REVLIMID; Product category: Drug; Primary reaction: Vaginal haemorrhage.
| Primary drug | REVLIMID |
|---|---|
| Product category | Drug |
| Primary reaction | Vaginal haemorrhage |
| All reactions | Vaginal haemorrhage |
| Seriousness | Serious |
| Patient outcome | Unknown |
| Patient sex | Female |
| All drugs reported | REVLIMID; REVLIMID; CENTRUM SILVER; ZOMETA |
| Reporter country | US |
| Reporter type | 3 |
| Report date | 20140313 |
| Report ID | 10006108 |
$299/mo
Try FDATracker →